A LOT HAS BEEN HAPPENING...READ SEAHECK'S POST:

New Post Public Reply Private Reply Replies (0) Message Board
CyberC
421
A LOT HAS BEEN HAPPENING...READ SEAHECK'S POST:


Seaheck Wednesday, 11/08/17 10:03:46 AM


Just wanted to post real quick. I know it's been a while, I'm just laying low while everything plays out over the next months.

So the FDA application was already completed when the pre clinical results were announced. A few things had to happen before they submitted the application. FDA approval into trials is anticipated to happen in 30-60 days (that's short and long expectation of a response).

Once we get notification from FDA, we are going to get a big "newsy" PR that will take the share price higher than anybody here has seen unless you've been in here for years. It should stay there also. Should be a great end of 2017, beginning pretty soon and that momentum should carry on through all of 2018, with expected FDA success plus the other pre clinicals finishing up and moving into FDA trials.

I'll post periodically if I have important news. Good things coming soon.

Endonovo Therapeutics, Inc. (ENDV) Stock Research Links

ENDV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors

Updated Category News Views 183

Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...

Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low

Updated Category News Views 120

Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 159

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion

Updated Category News Views 82

Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...

Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future

Updated Category News Views 8

Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...

Continue Reading